• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自然感染恙虫病东方体抗体可抑制HIV CXCR4(X4)病毒。

Natural Scrub Typhus Antibody Suppresses HIV CXCR4(X4) Viruses.

作者信息

Watt George, Kantipong Pacharee, Burnouf Thierry, Shikuma Cecilia, Philpott Sean

机构信息

Department of Medicine, John A. Burns School of Medicine, University of Hawai'i at Manoa , Honolulu, HI, USA.

Department of Internal Medicine, Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand.

出版信息

Infect Dis Rep. 2013 May 15;5(1):e8. doi: 10.4081/idr.2013.e8. eCollection 2013 Jan 22.

DOI:10.4081/idr.2013.e8
PMID:24470959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3892615/
Abstract

Viral load generally rises in HIV-infected individuals with a concomitant infection, but falls markedly in some individuals with scrub typhus (ST), a common Asian rickettsial infection. ST infection appears to shift the viral population from CXCR4-using (X4) to CCR5-utilizing (R5) strains, and there is evidence of cross-reactivity between ST-specific antibodies and HIV-1. We examined the mechanism of ST suppression of HIV by measuring the effects of ST infection on X4 and R5 viruses in vivo and in vitro, and assessing the relative contributions of antibodies and chemokines to the inhibitory effect. In vivo, a single scrub typhus plasma infusion markedly reduced the subpopulation of HIV-1 viruses using the X4 co-receptor in all 8 recipients, and eliminated X4 viruses 6 patients. In vitro, the 14 ST sera tested all inhibited the replication of an X4 but not an R5 virus. This inhibitory effect was maintained if ST sera were depleted of chemokines but was lost upon removal of antibodies. Sera from STinfected mice recognized a target that co-localized with X4 HIV gp120 in immunofluorescent experiments. These in vivo and in vitro data suggest that acute ST infection generates cross-reactive antibodies that produce potent suppression of CXCR4- but not CCR5-using HIV-1 viruses. ST suppression of HIV replication could reveal novel mechanisms that could be exploited for vaccination strategies, as well as aid in the development of fusion inhibitors and other new therapeutic regimens. This also appears to be the first instance where one pathogen is neutralized by antibody produced in response to infection by a completely unrelated organism.

摘要

在合并感染的HIV感染者中,病毒载量通常会升高,但在一些感染恙虫病(一种常见的亚洲立克次体感染)的个体中,病毒载量会显著下降。恙虫病感染似乎会使病毒群体从使用CXCR4的(X4)毒株转变为使用CCR5的(R5)毒株,并且有证据表明恙虫病特异性抗体与HIV-1之间存在交叉反应。我们通过测量恙虫病感染对体内和体外X4和R5病毒的影响,并评估抗体和趋化因子对抑制作用的相对贡献,来研究恙虫病抑制HIV的机制。在体内,单次输注恙虫病血浆在所有8名接受者中均显著降低了使用X4共受体的HIV-1病毒亚群,并且在6名患者中清除了X4病毒。在体外,所检测的14份恙虫病血清均抑制了X4病毒而非R5病毒的复制。如果恙虫病血清中的趋化因子被去除,这种抑制作用仍然存在,但去除抗体后则丧失。在免疫荧光实验中,来自感染恙虫病小鼠的血清识别出一个与X4 HIV gp120共定位的靶点。这些体内和体外数据表明,急性恙虫病感染产生交叉反应性抗体,这些抗体对使用CXCR4而非CCR5的HIV-1病毒产生强效抑制作用。恙虫病对HIV复制的抑制作用可能揭示可用于疫苗接种策略的新机制,也有助于融合抑制剂和其他新治疗方案的开发。这似乎也是首例一种病原体被针对完全无关生物体感染产生的抗体中和的情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7775/3892615/0e0a1a12b42e/idr-2013-1-e8-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7775/3892615/312f792d8258/idr-2013-1-e8-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7775/3892615/654c0d6e6ffc/idr-2013-1-e8-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7775/3892615/651ab2331b9d/idr-2013-1-e8-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7775/3892615/0e0a1a12b42e/idr-2013-1-e8-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7775/3892615/312f792d8258/idr-2013-1-e8-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7775/3892615/654c0d6e6ffc/idr-2013-1-e8-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7775/3892615/651ab2331b9d/idr-2013-1-e8-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7775/3892615/0e0a1a12b42e/idr-2013-1-e8-g004.jpg

相似文献

1
Natural Scrub Typhus Antibody Suppresses HIV CXCR4(X4) Viruses.自然感染恙虫病东方体抗体可抑制HIV CXCR4(X4)病毒。
Infect Dis Rep. 2013 May 15;5(1):e8. doi: 10.4081/idr.2013.e8. eCollection 2013 Jan 22.
2
In vitro reactivation of human immunodeficiency virus-1 upon stimulation with scrub typhus rickettsial infection.用恙虫病立克次体感染刺激后人类免疫缺陷病毒1型的体外再激活
Am J Trop Med Hyg. 2003 May;68(5):557-61. doi: 10.4269/ajtmh.2003.68.557.
3
Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.HIV-1 感染者血浆中存在具有不同核心受体使用偏好的复制型次要变异体。
J Virol. 2020 Jun 1;94(12). doi: 10.1128/JVI.00193-20.
4
HIV-1 suppression during acute scrub-typhus infection.恙虫病急性期HIV-1抑制作用
Lancet. 2000 Aug 5;356(9228):475-9. doi: 10.1016/S0140-6736(00)02557-5.
5
Mutations That Increase the Stability of the Postfusion gp41 Conformation of the HIV-1 Envelope Glycoprotein Are Selected by both an X4 and R5 HIV-1 Virus To Escape Fusion Inhibitors Corresponding to Heptad Repeat 1 of gp41, but the gp120 Adaptive Mutations Differ between the Two Viruses.突变增加了 HIV-1 包膜糖蛋白 gp41 的融合后构象稳定性,被 X4 和 R5 HIV-1 病毒选择以逃避针对 gp41 七肽重复 1 的融合抑制剂,但两种病毒的 gp120 适应性突变不同。
J Virol. 2019 May 15;93(11). doi: 10.1128/JVI.00142-19. Print 2019 Jun 1.
6
Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.与同一患者共存的利用CCR5的病毒变体相比,最近出现的利用CXCR4的人类免疫缺陷病毒1型毒株的中和敏感性增加。
J Virol. 2007 Jan;81(2):525-31. doi: 10.1128/JVI.01983-06. Epub 2006 Nov 1.
7
Next generation sequencing reveals a high frequency of CXCR4 utilizing viruses in HIV-1 chronically infected drug experienced individuals in South Africa.下一代测序技术揭示了南非慢性感染 HIV-1 的经历药物滥用者中 CXCR4 利用病毒的高频性。
J Clin Virol. 2018 Jun;103:81-87. doi: 10.1016/j.jcv.2018.02.008. Epub 2018 Feb 15.
8
Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals.从C亚型感染个体中分离出的CCR5嗜性和CXCR4嗜性1型人类免疫缺陷病毒生物学克隆的表型和基因型比较。
J Virol. 2004 Mar;78(6):2841-52. doi: 10.1128/jvi.78.6.2841-2852.2004.
9
Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains.对R5和X4病毒株具有广泛活性的HIV-1进入抑制剂的特性分析。
J Transl Med. 2015 Apr 2;13:107. doi: 10.1186/s12967-015-0461-9.
10
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.HIV-1 双重/混合嗜性分离株表现出不同的遗传和表型特征以及对马拉维若的体外反应。
Antiviral Res. 2011 Apr;90(1):42-53. doi: 10.1016/j.antiviral.2011.02.005. Epub 2011 Feb 22.

引用本文的文献

1
An atlas of human vector-borne microbe interactions reveals pathogenicity mechanisms.人类载体传播微生物相互作用图谱揭示致病机制。
Cell. 2024 Jul 25;187(15):4113-4127.e13. doi: 10.1016/j.cell.2024.05.023. Epub 2024 Jun 13.
2
The Manifesto of Pharmacoenosis: Merging HIV Pharmacology into Pathocoenosis and Syndemics in Developing Countries.《药物群落宣言:将艾滋病药理学融入发展中国家的病理群落和疾病流行学》
Microorganisms. 2021 Jul 31;9(8):1648. doi: 10.3390/microorganisms9081648.
3
Clinical and Laboratory Characteristics of Dengue-Orientia tsutsugamushi co-Infection from a Tertiary Care Center in South India.

本文引用的文献

1
AIDS/HIV. A boost for HIV vaccine design.艾滋病/艾滋病毒。对艾滋病毒疫苗设计的推动。
Science. 2010 Aug 13;329(5993):770-3. doi: 10.1126/science.1194693.
2
Chronic herpes simplex virus type-2 infection and HIV viral load.慢性2型单纯疱疹病毒感染与HIV病毒载量
Int J STD AIDS. 2005 Nov;16(11):733-5. doi: 10.1258/095646205774763298.
3
Structure of a V3-containing HIV-1 gp120 core.含V3区的HIV-1 gp120核心结构。
印度南部一家三级医疗中心登革热-恙虫病东方体合并感染的临床和实验室特征
Mediterr J Hematol Infect Dis. 2016 Jun 16;8(1):e2016028. doi: 10.4084/MJHID.2016.028. eCollection 2016.
4
A comparative hospital-based observational study of mono- and co-infections of malaria, dengue virus and scrub typhus causing acute undifferentiated fever.一项基于医院的关于疟疾、登革热病毒和恙虫病单重感染及混合感染导致急性未分化发热的比较观察性研究。
Eur J Clin Microbiol Infect Dis. 2016 Apr;35(4):705-11. doi: 10.1007/s10096-016-2590-3. Epub 2016 Feb 6.
Science. 2005 Nov 11;310(5750):1025-8. doi: 10.1126/science.1118398.
4
Attenuation of HIV-1 infection by other microbial agents.
J Infect Dis. 2005 Sep 15;192(6):1003-9. doi: 10.1086/432767. Epub 2005 Aug 12.
5
Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies.通过人源中和抗体的被动转移在抗逆转录病毒治疗停止后延迟HIV-1反弹。
Nat Med. 2005 Jun;11(6):615-22. doi: 10.1038/nm1244. Epub 2005 May 8.
6
Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study.恶性疟原虫疟疾对马拉维农村地区成年人血液中HIV-1-RNA浓度的影响:一项前瞻性队列研究。
Lancet. 2005;365(9455):233-40. doi: 10.1016/S0140-6736(05)17743-5.
7
Evolution of human immunodeficiency virus type 1 coreceptor usage during antiretroviral Therapy: a Bayesian approach.抗逆转录病毒治疗期间人类免疫缺陷病毒1型辅助受体使用情况的演变:一种贝叶斯方法。
J Virol. 2004 Oct;78(20):11296-302. doi: 10.1128/JVI.78.20.11296-11302.2004.
8
Scrub typhus and tropical rickettsioses.恙虫病和热带立克次体病。
Curr Opin Infect Dis. 2003 Oct;16(5):429-36. doi: 10.1097/00001432-200310000-00009.
9
Decrease in human immunodeficiency virus type 1 load during acute dengue fever.急性登革热期间1型人类免疫缺陷病毒载量的下降
Clin Infect Dis. 2003 Apr 15;36(8):1067-9. doi: 10.1086/374600. Epub 2003 Apr 4.
10
Suppression of human immunodeficiency virus replication during acute measles.
J Infect Dis. 2002 Apr 15;185(8):1035-42. doi: 10.1086/340027. Epub 2002 Mar 25.